258 related articles for article (PubMed ID: 19463683)
1. Estrogen receptor beta in breast cancer--diagnostic and therapeutic implications.
Hartman J; Ström A; Gustafsson JA
Steroids; 2009 Aug; 74(8):635-41. PubMed ID: 19463683
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
3. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
Rajah TT; Du N; Drews N; Cohn R
Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
[TBL] [Abstract][Full Text] [Related]
4. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
Power KA; Thompson LU
Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of estrogen receptor beta in breast cancer.
Saji S; Hirose M; Toi M
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():21-6. PubMed ID: 16273360
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptors and proliferation markers in primary and recurrent breast cancer.
Jensen EV; Cheng G; Palmieri C; Saji S; Mäkelä S; Van Noorden S; Wahlström T; Warner M; Coombes RC; Gustafsson JA
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15197-202. PubMed ID: 11734621
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients.
Altundag O; Altundag K; Gunduz M
Med Hypotheses; 2004; 63(4):684-7. PubMed ID: 15325017
[TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
[TBL] [Abstract][Full Text] [Related]
11. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts.
Hartman J; Lindberg K; Morani A; Inzunza J; Ström A; Gustafsson JA
Cancer Res; 2006 Dec; 66(23):11207-13. PubMed ID: 17145865
[TBL] [Abstract][Full Text] [Related]
13. Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer.
Koda M; Sulkowski S; Kanczuga-Koda L; Surmacz E; Sulkowska M
Oncol Rep; 2004 Apr; 11(4):753-9. PubMed ID: 15010868
[TBL] [Abstract][Full Text] [Related]
14. Steroid hormone receptor expression in male breast cancer.
Murphy CE; Carder PJ; Lansdown MR; Speirs V
Eur J Surg Oncol; 2006 Feb; 32(1):44-7. PubMed ID: 16260112
[TBL] [Abstract][Full Text] [Related]
15. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
McCarty MF
Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
[TBL] [Abstract][Full Text] [Related]
16. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells.
Hodges-Gallagher L; Valentine CD; El Bader S; Kushner PJ
Breast Cancer Res Treat; 2008 May; 109(2):241-50. PubMed ID: 17638070
[TBL] [Abstract][Full Text] [Related]
19. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
[TBL] [Abstract][Full Text] [Related]
20. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines.
Treeck O; Juhasz-Boess I; Lattrich C; Horn F; Goerse R; Ortmann O
Breast Cancer Res Treat; 2008 Aug; 110(3):507-20. PubMed ID: 17876701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
